Skip to main navigation Skip to search Skip to main content

Nipah Virus: Elevated Risk, Morbidity, and Mortality, the Need for Vaccines

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Abstract

    Globally, mankind witnessed the newly emerging variants of Coronavirus and their impacts, which became traumatic for all. The scientific and medical communities relentlessly worked for solutions to this problem. The probability of mortality due to Coronavirus is much lower, when compared with Nipah virus. Recently, there have been many outbreaks of Nipah in several countries, including India. Fortunately, the healthcare officers were able to contain the spread within each outbreak area. Currently, there is an urgent need to protect vulnerable populations by vaccination because of the uncertainties of repeated outbreaks. Here, an attempt is made to summarize the recent specifics about Nipah virus including its symptoms, prevention methods, epidemiology, proteomic information, structural data, evolutionary data, and treatment strategies.

    Original languageEnglish
    Title of host publicationGlobal Virology V
    Subtitle of host publication21st Century Vaccines and Viruses
    PublisherSpringer Science + Business Media
    Pages137-151
    Number of pages15
    ISBN (Electronic)9783031779114
    ISBN (Print)9783031779107
    DOIs
    Publication statusPublished - 01-01-2025

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    All Science Journal Classification (ASJC) codes

    • General Immunology and Microbiology
    • General Medicine

    Fingerprint

    Dive into the research topics of 'Nipah Virus: Elevated Risk, Morbidity, and Mortality, the Need for Vaccines'. Together they form a unique fingerprint.

    Cite this